Calling all APPs! Come join the incredible #skullbase team MD Anderson Cancer Center! We’re looking for a dedicated, compassionate team player to join a busy clinic. Apply today and join the fight to #endcancer! ⬇️ careers.mdanderson.org/jobs/advance-p…

Join us for the Inaugural Tumor Soirée hosted by the NS Tumor Section ECNC at AANS Boston. An evening of insightful case discussions, networking and fine dining. Limited spots are available, sign up now! 🍽️🧠 #AANS2025 #TumorSoiree ow.ly/E4Ot50V7PWb

Check out our work - just published in JNO! We present 16 patients with extra-CNS mets from high-grade glioma, an exceedingly rare phenomenon. Jeffrey S. Weinberg Caroline Brennan Frederick Lang, MD Kadir C Akdemir Maria Gule-Monroe MD Journal of Neuro-Oncology link.springer.com/article/10.100…

Amazing work from the Neurosurgery team at MD Anderson Cancer Center! Check out our latest in Journal of Neuro-Oncology ⬇️

Genetically engineered macrophages home to inflammation, can “eat” tumor cells, and could help fight #braincancer. Listen to Chiba Ene describe his work in the MD Anderson Cancer Center lab at our recent Neurosurgery Grand Rounds! ⬇️ mdanderson.org/research/depar…

BREAKING from NEJM In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) is : 🔘Noninferior to full-dose (5 mg BID) for VTE recurrence 🔘Lower bleeding risk (12.1% vs. 15.6%) 🔘Safer extended anticoagulation, same protection.

🚨Friday, April 11, 12 noon CST🚨 Dr. Nduka Amankulor, MD joins the MD Anderson Cancer Center Brain Tumor Program seminar series from Penn Neurosurgery! We’ll be discussing gliomas and research to #endcancer. Email [email protected] for login details 👩‍💻

Join us this Friday when we host Nduka Amankulor, MD and hear about his groundbreaking work on immune evasion in gliomas! Frederick Lang, MD Jeffrey S. Weinberg Franco DeMonte

Excited about NS Tumor Section's next webinar! Come learn about Management of Recurrent Glioblastoma with Manish Aghi, MD PhD from UCSF Neurosurgery in Latest Highlights in Neurosurgical Oncology series on 04/16/25 at 3:30pm CST. Register here: rebrand.ly/mka041625

Powerful session with Manish Aghi, MD PhD (UCSF Neurosurgery) on managing recurrent glioblastoma—honored to hear from a leader in the field. NS Tumor Section Costas Hadjipanayis Ankush Chandra, MD, MS Ashish H. Shah

Join us tomorrow to hear about our Liquid biopsy program for brain tumors led by Dr. Ballester!

Our NS Tumor Section Tumor Soirée is well underway. Recognizing Randy Jensen from University of Utah by our Early Career Neurosurgeons. Incredible effort organizing the event by Yoshua Esquenazi, M.D, FAANS Ankush Chandra, MD, MS Ashish Shah to make this happen AANS Davio's Northern Italian Steakhouse

This years AACR conference highlights is focused on the next generation of brain tumors scientists MD Anderson Cancer Center working to #endcancer!

Join the MD Anderson Cancer Center #BrainTumor seminar series tomorrow, via Zoom! Dr. Qi Ye will present the latest research on #astrocytes, #glioma and stroke ⬇️ 🧠 May 16, 2025 🧠12 noon CST 🧠 Contact [email protected] for login details #BTAM #GoGrayInMay

For Brain Tumor Awareness Month, join us to hear from Dr. Gartrell about FLASH RT for pediatric brain tumors!! #endcancer MD Anderson Cancer Center

“Intra-arterial delivery has the potential to more effectively deliver therapeutics.” Chris Young, MD PhD described our groundbreaking endovascular neurosurgical oncology program to a packed room of residents and fellows at MD Anderson Cancer Center today! #oncsurgery #btam #endcancer

Get the latest on MD Anderson Cancer Center research from the ASCO conference! Drs. Anuj Patel and Jordi Ahnert will present current cancer and #braintumor research on Zoom. Here’s the info ⬇️ 🗓️Friday, June 20 🕕12 pm CST 📧 [email protected] to sign up!

So excited to have the Society of Neurological Surgeons Intern Boot Camp kick off. Thanks to our course directors Rob North and Nisha Gadgil BCM Neurosurgery

Today’s Neurosurgery Grand Rounds was packed with residents and fellows! Dr. Claudio Tatsui described how MD Anderson Cancer Center neurosurgeons optimize #oncsurgery outcomes using radiation therapy for spine mets. We”re leading in technological innovation to #endcancer.

A first for DMG (formerly known as DIPG): the FDA has approved dordaviprone (Modeyso), previously known as ONC201. We’re proud to have played a role in this milestone for #braintumor patients who have historically had desperately few treatment options. bit.ly/3J2XVTi